Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guidelines
- PMID: 38911219
- PMCID: PMC11190518
- DOI: 10.21037/hbsn-24-63
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guidelines
Keywords: Gallbladder cancer; bile duct cancer; cholangiocarcinoma; guidelines; hepatic artery infusion pump.
Conflict of interest statement
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-24-63/coif). A.V.M. reports grant from National Institutes of Health, National Cancer Institute (No. R37CA238485) and he is the inventor on record for US20140377274A1 and US11732305B2, and serves on service committees for surgical societies. The author has no other conflicts of interest to declare.
Comment on
-
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.Ann Oncol. 2023 Feb;34(2):127-140. doi: 10.1016/j.annonc.2022.10.506. Epub 2022 Nov 10. Ann Oncol. 2023. PMID: 36372281 No abstract available.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources